We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

97 hedge funds and large institutions have $92.1M invested in Avid Bioservices, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 27 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $91.9M → $92.1M (+$230K)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 27

4% less funds holding

Funds holding: 10197 (-4)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

Holders
97
Holders Change
-4
Holders Change %
-3.96%
% of All Funds
2.1%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
11
Increased
27
Reduced
27
Closed
14
Calls
$142K
Puts
Net Calls
+$142K
Net Calls Change
+$8K
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
101
Jane Street
New York
-$82K -19,944 Closed
MLICM
102
Metropolitan Life Insurance Company (MetLife)
New York
-$75.6K -18,436 Closed
VF
103
Virtu Financial
New York
-$71K -17,402 Closed
DWA
104
Dorsey Wright & Associates
California
-$11K -2,642 Closed
SGS
105
Sterling Global Strategies
California
-$5.86K -1,429 Closed
PHK
106
Point72 Hong Kong
Hong Kong
-$2K -459 Closed
FGAM
107
Financial Gravity Asset Management
Texas
+$477 +117 New

CDMO Hedge Fund Activity: Q1 2019 in Review

97 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q1 2019, worth a combined $92.1M — up 0.25% from $91.9M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CDMO and 11 opened new positions — a net loss of 3 holders — while 27 trimmed existing stakes and 27 added.

The largest buyer was AltraVue Capital, adding an estimated $2.67M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $3.17M sold.

  • 97 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q1 2019, down from 101 in Q4 2018.
  • Funds reported $92.1M of Avid Bioservices, Inc. Common Stock stock for Q1 2019, up 0.25% quarter-over-quarter.
  • 11 funds opened new Avid Bioservices, Inc. Common Stock positions in Q1 2019 and 14 closed out, a net change of -3 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q1 2019 was AltraVue Capital, an estimated $2.67M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q1 2019 was Driehaus Capital Management, an estimated $3.17M sold.

Based on aggregated 13F filings for Q1 2019.